Explore Biotech Products, Systems and Solutions

From concept through to design, biotech validation and production across all biotech applications, we can help you adapt to changing market conditions

with innovative technologies and solutions. Whether that means quickly developing a process for a new drug, vaccine production, helping you ensure regulatory compliance,
or making existing processes easier, faster and better, we are ready to work with you to address your process needs.



Gene Therapy Viral Vector Production


Overcome development and viral vector manufacturing obstacles to accelerate delivery of commercially viable gene therapies to patients.


Monoclonal Antibodies and Recombinant Proteins


A portfolio to support all your monoclonal antibody production choices, including traditional manufacturing methods and single-use alternatives.


Vaccine Production



Enhanced solutions to meet the most difficult vaccine development and manufacturing challenges, and your specific vaccine production needs.


Are You Ready?



Allegro™ Ready systems are configurable single-use systems for storage, fluid transfer, and filtration - get a quote today with our Selection Guide.




Blog Post

Shahin Heshmatifar and Kyle Burrell take a look at bioreactors and review the various types and applications they are used in.

They share a brief history of bioreactor applications since their first appearance at the start of the 20th century, and look towards future developments and potential.

On-Demand Webinar

In this webinar, we will present our scalable integrated platforms for viral vector production in both adherent and suspension cell cultures. You will learn how to achieve versatility with a scalable, single-use end-to-end platform and optimize small-scale expression systems.


Todd Lundeen and Andrew Laskowski take a detailed, technical look at how Aber’s FUTURA biomass proble provides reliable measurements when used with the iCELLis® nano bioreactor, correlating cumulative glucose consumption, nuclei counts and capacitance.


White Paper: Manufacturing Challenges of High Concentration Biotech Drugs 


Growth in the formulation of drugs suitable for delivery by subcutaneous injection has highlighted manufacturing challenges  associated with the higher concentration of active ingredients required to achieve the low dose volumes delivered to patients.
However, solutions to maintain quality, maximize process yield and product recovery are available and can easily be introduced to adapt an existing manufacturing platform to support the new process requirements. 

Tom Watson, (Group Leader, Product Management for Direct Flow Filtration and Formulation and Filling) explains, and our recent white paper discusses these challenges and looks at potential solutions.

All the latest news and offers direct to your inbox

Sign up today to get the latest industry insights emailed to you, plus news, trends, early notice of new webinars and virtual events, special offers, invitations, discount codes and promotions. We'll also keep you informed of many groundbreaking new technologies, solutions and products.

Integrated Solutions

Moving to integrated solutions will help simplify and streamline your manufacturing process, speeding time to market and reducing overall cost of goods. The simplified process using standard equipment, qualified designs and components lowers the risk for operator error, which helps assure compliance with cGMP and assure product quality. Our integrated solutions team combines best engineering and project management practices with in-depth industry knowledge and diverse equipment portfolio to deliver these benefits on time, and on budget.


Accelerator℠ Documentation Center

Transparency and partnership are at our heart. We know the availability of high quality product documentation helps manage the documentation required for regulatory submission.
The Accelerator Documentation Center collates all current documentation to help you navigate compliance quickly and efficiently, and the electronic regulatory dossiers help you in your ongoing risk assessments to help alleviate the pressures of preparing documentation for regulatory compliance and audits.